Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2017 (2017), Article ID 9857918, 12 pages
https://doi.org/10.1155/2017/9857918
Research Article

Electrophysiological, Morphological, and Ultrastructural Features of the Injured Spinal Cord Tissue after Transplantation of Human Umbilical Cord Blood Mononuclear Cells Genetically Modified with the VEGF and GDNF Genes

1Kazan Federal University, Kazan, Russia
2Kazan State Medical University, Kazan, Russia
3Republic Clinical Hospital, Kazan, Russia
4Kazan State Academy of Veterinary Medicine, Kazan, Russia

Correspondence should be addressed to Y. O. Mukhamedshina; ur.liam@n-z-k.anay

Received 19 September 2016; Accepted 24 January 2017; Published 21 March 2017

Academic Editor: J. Michael Wyss

Copyright © 2017 Y. O. Mukhamedshina et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S.-U. Kuh, Y.-E. Cho, D.-H. Yoon, K.-N. Kim, and Y. Ha, “Functional recovery after human umbilical cord blood cells transplantation with brain-derived neutrophic factor into the spinal cord injured rat,” Acta Neurochirurgica, vol. 147, no. 9, pp. 985–992, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. H. M. Kim, D. H. Hwang, J. E. Lee, S. U. Kim, and B. G. Kim, “Ex Vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury,” PLoS ONE, vol. 4, no. 3, Article ID e4987, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. L. L. Jones, M. Oudega, M. B. Bunge, and M. H. Tuszynski, “Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury,” Journal of Physiology, vol. 533, no. 1, pp. 83–89, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Gowing, B. Shelley, K. Staggenborg et al., “Glial cell line-derived neurotrophic factor-secreting human neural progenitors show long-term survival, maturation into astrocytes, and no tumor formation following transplantation into the spinal cord of immunocompromised rats,” NeuroReport, vol. 25, no. 6, pp. 367–372, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. D. H. Hwang, B. G. Kim, E. J. Kim et al., “Transplantation of human neural stem cells transduced with Olig2 transcription factor improves locomotor recovery and enhances myelination in the white matter of rat spinal cord following contusive injury,” BMC Neuroscience, vol. 10, article no. 117, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. D.-H. Park, J.-H. Lee, C. V. Borlongan, P. R. Sanberg, Y.-G. Chung, and T.-H. Cho, “Transplantation of umbilical cord blood stem cells for treating spinal cord injury,” Stem Cell Reviews and Reports, vol. 7, no. 1, pp. 181–194, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A.-J. Shang, S.-Q. Hong, Q. Xu et al., “NT-3-secreting human umbilical cord mesenchymal stromal cell transplantation for the treatment of acute spinal cord injury in rats,” Brain Research, vol. 1391, pp. 102–113, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. O. Mukhamedshina, G. F. Shaymardanova, E. E. Garanina et al., “Adenoviral vector carrying glial cell-derived neurotrophic factor for direct gene therapy in comparison with human umbilical cord blood cell-mediated therapy of spinal cord injury in rat,” Spinal Cord, vol. 54, no. 5, pp. 347–359, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. G. F. Shaǐmardanova, I. O. Mukhamedshina, A. A. rizvanov, I. I. Salafutdinov, and I. A. Chelyshev, “Effects of transplantation of human umbilical cord blood mononuclear cells, expressing VEGF and FGF2 genes, into the area of spinal cord traumatic lesion,” Morfologii, vol. 142, no. 4, pp. 31–36, 2012. View at Google Scholar · View at Scopus
  10. G. F. Shaǐmardanova, I. O. Mukhamedshina, S. S. Arkhipova, I. I. Salafutdinov, A. A. Razvanov, and I. A. Chelyshev, “Posttraumatic changes of rat spinal cord after transplantation of human umbilical cord blood mononuclear cells transfected with VEGF and FGF2 genes,” Morfologiia, vol. 140, no. 6, pp. 36–42, 2011. View at Google Scholar · View at Scopus
  11. R. R. Islamov, V. Chintalgattu, E. S. Pak, L. C. Katwa, and A. K. Murashov, “Induction of VEGF and its Flt-1 receptor after sciatic nerve crush injury,” NeuroReport, vol. 15, no. 13, pp. 2117–2121, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Sondell, G. Lundborg, and M. Kanje, “Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system,” Journal of Neuroscience, vol. 19, no. 14, pp. 5731–5740, 1999. View at Google Scholar · View at Scopus
  13. H. Qiang, C. Zhang, Z. Shi, and M. Ling, “Neuroprotective effects of recombinant adeno-associated virus expressing vascular endothelial growth factor on rat traumatic spinal cord injury and its mechanism,” Chinese Journal of Reparative and Reconstructive Surgery, vol. 26, no. 6, pp. 724–730, 2012. View at Google Scholar · View at Scopus
  14. D. Perrelet, A. Ferri, P. Liston, P. Muzzin, R. G. Korneluk, and A. C. Kato, “IAPs are essential for GDNF-mediated neuroprotective effects in injured motor neurons in vivo,” Nature Cell Biology, vol. 4, no. 2, pp. 175–179, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Cheng, J.-P. Wu, and S.-F. Tzeng, “Neuroprotection of glial cell line-derived neurotrophic factor in damaged spinal cords following contusive injury,” Journal of Neuroscience Research, vol. 69, no. 3, pp. 397–405, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Mackenzie and C. Ruhrberg, “Diverse roles for VEGF-A in the nervous system,” Development, vol. 139, no. 8, pp. 1371–1380, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. C. D. Mills, A. J. Allchorne, R. S. Griffin, C. J. Woolf, and M. Costigan, “GDNF selectively promotes regeneration of injury-primed sensory neurons in the lesioned spinal cord,” Molecular and Cellular Neuroscience, vol. 36, no. 2, pp. 185–194, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Zhang, Z. Ma, G. M. Smith et al., “GDNF-enhanced axonal regeneration and myelination following spinal cord injury is mediated by primary effects on neurons,” GLIA, vol. 57, no. 11, pp. 1178–1191, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Facchiano, E. Fernandez, S. Mancarella et al., “Promotion of regeneration of corticospinal tract axons in rats with recombinant vascular endothelial growth factor alone and combined with adenovirus coding for this factor,” Journal of Neurosurgery, vol. 97, no. 1, pp. 161–168, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Jin, M.-L. Liu, H. A. Kim et al., “Role of the oxygen-dependent degradation domain in a hypoxia-inducible gene expression system in vascular endothelial growth factor gene therapy,” Spine, vol. 34, no. 26, pp. E952–E958, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Sondell, F. Sundler, and M. Kanje, “Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor,” European Journal of Neuroscience, vol. 12, no. 12, pp. 4243–4254, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Iwase, C. G. Jung, H. Bae, M. Zhang, and B. Soliven, “Glial cell line-derived neurotrophic factor-induced signaling in Schwann cells,” Journal of Neurochemistry, vol. 94, no. 6, pp. 1488–1499, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. O. Mukhamedshina, E. E. Garanina, G. A. Masgutova et al., “Assessment of glial scar, tissue sparing, behavioral recovery and axonal regeneration following acute transplantation of genetically modified human umbilical cord blood cells in a rat model of spinal cord contusion,” PLoS ONE, vol. 11, no. 3, Article ID e0151745, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Brouwer, J. Bugaresti, and P. Ashby, “Changes in corticospinal facilitation of lower limb spinal motor neurons after spinal cord lesions,” Journal of Neurology, Neurosurgery, and Psychiatry, vol. 55, no. 1, pp. 20–24, 1992. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Zhu, W. Poon, Y. Liu et al., “Phase I-II clinical trial assessing safety and efficacy of umbilical cord blood mononuclear cell transplant therapy of chronic complete spinal cord injury,” Cell Transplantation, vol. 25, no. 11, pp. 1925–1943, 2016. View at Publisher · View at Google Scholar
  26. R. R. Islamov, A. A. Rizvanov, M. A. Mukhamedyarov et al., “Symptomatic improvement, increased life-span and sustained cell homing in amyotrophic lateral sclerosis after transplantation of human umbilical cord blood cells genetically modified with adeno-viral vectors expressing a neuro-protective factor and a neural cell adhesion molecule,” Current Gene Therapy, vol. 15, no. 3, pp. 266–276, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Zawadzka, L. E. Rivers, S. P. J. Fancy et al., “CNS-resident glial progenitor/stem cells produce schwann cells as well as oligodendrocytes during repair of CNS demyelination,” Cell Stem Cell, vol. 6, no. 6, pp. 578–590, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. O. Mukhamedshina, G. F. Shaymardanova, I. I. Salafutdinov et al., “Delivery of cord blood cells modified with adenoviral vectors expressing GDNF into the area of spinal cord injury stimulates recovery of motor function and supports a population of glial cells,” Cellular Transplantation and Tissue Engineering, vol. 8, no. 3, pp. 129–132, 2013. View at Google Scholar · View at Scopus